Sep 6, 2022 | Eating, Featured, Foods, Research News, Technology Updates
Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022. Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Aug 15, 2022 | Advocacy, Featured, Research News, Technology Updates
Final Day: Make Your Voice Heard AGAIN to the FDA re CGM! Here’s another chance to tell them, in a few short sentences, what you want, regarding CGM (continuous glucose monitoring) alarms! The FDA has mandated that CGM LOW BG alarms MAY NOT be turned off or...
Jul 25, 2022 | Advocacy, Featured, Research News, Technology Updates
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Jul 18, 2022 | Advocacy, Featured, Foods, Technology Updates
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Jul 11, 2022 | Advocacy, Featured, Foods, Technology Updates
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
Jul 5, 2022 | Advocacy, Featured, Research News, Technology Updates
The ENTIRE Diabetes Community needs you to take action. The US FDA held a webinar on Cybersecurity in Medical Devices in June 2022, asking for feedback and comments, accepted through 7 July 2022. Time is of the ESSENCE! At issue: Unlimited,...